CATALOGO DEI PRODOTTI DELLA RICERCA

ARTIBANI, Walter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.041
EU - Europa 13.748
AS - Asia 11.385
SA - Sud America 1.500
Continente sconosciuto - Info sul continente non disponibili 563
AF - Africa 301
OC - Oceania 46
Totale 47.584
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.288
RU - Federazione Russa 5.456
SG - Singapore 4.399
CN - Cina 3.568
GB - Regno Unito 2.342
IT - Italia 1.320
BR - Brasile 1.120
SE - Svezia 933
VN - Vietnam 910
HK - Hong Kong 907
FR - Francia 873
DE - Germania 753
IE - Irlanda 727
FI - Finlandia 571
KR - Corea 378
CA - Canada 357
BD - Bangladesh 257
UA - Ucraina 194
IN - India 174
JP - Giappone 140
AR - Argentina 136
TR - Turchia 122
MX - Messico 99
ID - Indonesia 89
NL - Olanda 89
ES - Italia 81
ZA - Sudafrica 70
PL - Polonia 67
IQ - Iraq 65
NG - Nigeria 62
CO - Colombia 59
BE - Belgio 56
CR - Costa Rica 49
PK - Pakistan 45
AU - Australia 43
VE - Venezuela 43
AT - Austria 42
EC - Ecuador 42
MA - Marocco 36
IL - Israele 34
TT - Trinidad e Tobago 34
SA - Arabia Saudita 33
GT - Guatemala 31
LT - Lituania 30
PH - Filippine 29
AE - Emirati Arabi Uniti 28
CL - Cile 28
PY - Paraguay 28
CW - ???statistics.table.value.countryCode.CW??? 27
JM - Giamaica 26
MY - Malesia 26
SV - El Salvador 26
CZ - Repubblica Ceca 25
NI - Nicaragua 24
HN - Honduras 23
KE - Kenya 23
EG - Egitto 22
UZ - Uzbekistan 21
DK - Danimarca 20
GP - Guadalupe 20
TN - Tunisia 20
CH - Svizzera 19
PE - Perù 18
JO - Giordania 15
PR - Porto Rico 15
AZ - Azerbaigian 14
LV - Lettonia 14
NP - Nepal 13
PA - Panama 13
AL - Albania 12
BG - Bulgaria 12
UY - Uruguay 12
BO - Bolivia 11
DZ - Algeria 11
KG - Kirghizistan 11
RO - Romania 11
SC - Seychelles 11
SI - Slovenia 11
BB - Barbados 10
GR - Grecia 10
LB - Libano 10
OM - Oman 10
PT - Portogallo 10
RS - Serbia 10
HR - Croazia 9
HU - Ungheria 9
TH - Thailandia 9
AM - Armenia 8
CY - Cipro 8
EU - Europa 8
IR - Iran 8
KZ - Kazakistan 8
SK - Slovacchia (Repubblica Slovacca) 8
EE - Estonia 7
ET - Etiopia 7
KH - Cambogia 7
CI - Costa d'Avorio 6
LK - Sri Lanka 6
PS - Palestinian Territory 6
SN - Senegal 6
Totale 46.943
Salva come PNG Salva come JPEG
Città #
Ashburn 2.681
Singapore 2.373
Southend 1.883
San Jose 1.720
Moscow 1.670
Chandler 1.607
Dallas 1.189
Jacksonville 1.095
Woodbridge 1.008
Hong Kong 885
Ann Arbor 755
Beijing 746
Dublin 725
Council Bluffs 652
The Dalles 611
Houston 534
Verona 531
New York 468
Los Angeles 370
Wilmington 320
Ho Chi Minh City 311
Lawrence 305
Princeton 304
Jinan 264
Dearborn 222
Nanjing 217
Santa Clara 186
Helsinki 183
Hanoi 167
Shenyang 166
São Paulo 163
Columbus 132
Buffalo 130
Tianjin 126
Tokyo 125
Hebei 120
Redondo Beach 119
Milan 111
Munich 109
Montreal 102
Haikou 95
Sindelfingen 93
Guangzhou 82
Changsha 81
Orem 81
Zhengzhou 81
Ningbo 78
Frankfurt am Main 73
Chicago 72
Denver 70
Atlanta 69
Seattle 69
Fuzhou 65
Nanchang 65
Hangzhou 64
Redwood City 64
Toronto 64
Dong Ket 62
Brooklyn 60
London 59
Abuja 56
Phoenix 56
Rome 55
Seoul 55
Warsaw 55
San Francisco 54
Falls Church 53
Jiaxing 53
Taiyuan 53
Redmond 52
Brussels 49
Stockholm 49
Boardman 48
Johannesburg 47
Norwalk 47
Volga 47
Chennai 46
Taizhou 44
Las Vegas 43
San José 43
Manchester 41
Turku 41
Mexico City 40
Amsterdam 37
North Bergen 37
Rio de Janeiro 37
Da Nang 36
Detroit 36
Jakarta 36
Poplar 35
Kent 34
Boston 33
Saint Petersburg 32
Haiphong 30
Fairfield 28
Bologna 27
Paris 27
Washington 27
Ankara 26
Shanghai 26
Totale 28.503
Salva come PNG Salva come JPEG
Nome #
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 267
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 262
Along the pituitary-testis-prostate axis, serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups. 255
ROLE OF SYMPTOMS DURATION AS PROGNOSTICATOR FOR SACRAL NEUROMODULATION IN REFRACTORY OVERACTIVE BLADDER 247
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 244
A new training model for robot-assisted urethrovesical anastomosis and posterior muscle-fascial reconstruction: the Verona training technique 242
PD45-01 ASSOCIATION OF LOCAL ANAESTHETIC WOUNDS INFILTRATION AND ULTRASOUND TRANSVERSUS ABDOMINAL PLANE (US-TAP) BLOCK IN PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL 241
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 240
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 240
Argus-T Sling in 182 Male Patients: Short-term Results of a Multicenter Study 238
A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder 235
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 235
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 232
A PILOT RANDOMIZED TRIAL OF PREOPERATIVE PELVIC FLOOR MUSCLE EXERCISE VS USUAL CARE TO IMPROVE SEXUAL FUNCTION AND HEALTH RELATED QUALITY OF LIVE AFTER RARP: PRELIMINARY DISAPPOINTED RESULTS 232
90-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series 231
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 231
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 229
Adenocarcinoma of the paraurethral glands: a case report 227
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 227
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 226
Acute Ischemia of the Glans Penis after Circumcision Treated with Hyperbaric Therapy and Pentoxifylline: Case Report and Revision of the Literature 226
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 220
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 220
Liver Metastases From Renal Oncocytoma With Vascular Extension 217
Extended pelvic lymphadenectomy for prostate cancer: should the cloquet's nodes dissection be considered only an option? 217
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 215
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 215
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 214
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 214
Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study 212
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 212
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 212
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 211
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 211
Association between postoperative thromboembolism prophylaxis and complications following urological surgery 209
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 208
A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. 208
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 208
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series 207
Impairment in Activities of Daily Living Assessed by the Barthel Index Predicts Adverse Oncological Outcomes After Radical Cystectomy for Bladder Cancer 206
An Overview on Mixed Action Drugs for the Treatment of Overactive Bladder and Detrusor Overactivity 206
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 206
How radical prostatectomy procedures have changed over the last 10~years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 206
COMPLICATIONS AND QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION 203
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 203
Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies 203
A COMPARISON OF SCHAEFER, INTERNATIONAL CONTINENCE SOCIETY AND BLADDER CONTRACTILITY INDEX NOMOGRAMS IN THE DIAGNOSIS OF OBSTRUCTION AND DETRUSOR UNDERACTIVITY IN MEN WITH LOWER URINARY TRACT SYMPTOMS 203
A case of eosinophilic cystitis in patients with abdominal pain, dysuria, genital skin hyperemia and slight toxocariasis. 202
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 202
Impact of Combination of Local Anesthetic Wounds Infiltration and Ultrasound Transversus Abdominal Plane Block in Patients Undergoing Robot-Assisted Radical Prostatectomy: Perioperative Results of a Double-Blind Randomized Controlled Trial 200
HEALTH-RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY IN SURVIVED PATIENTS WITH AN ILEAL CONDUIT OR ILEAL ORTHOTOPIC NEOBLADDER DIVERSION: A COMPARATIVE PROPENSITY-SCORE MATCHED ANALYSIS 200
MP5-16 QUALITY OF LIFE OF 171 PATIENTS WITH BLADDER CANCER UNDERGOING ILEAL ORTHOTOPIC NEOBLADDER: A MULTICENTRE STUDY AMONG LONG-TERM SURVIVORS 199
Antegrade scrotal sclerotherapy in the treatment of varicocele: a prospective study. 198
AR-V7 and prostate cancer: The watershed for treatment selection? 198
A COMPARISON OF SCHAEFER, INTERNATIONAL CONTINENCE SOCIETY AND BLADDER CONTRACTILITY INDEX NOMOGRAMS IN THE DIAGNOSIS OF OBSTRUCTION AND DETRUSOR UNDERACTIVITY IN MEN WITH LOWER URINARY TRACT SYMPTOMS 198
Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection 198
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 197
Bone density and skeletal metabolism in patients with orthotopic ileal neobladder. 195
Impact of anatomical pielocaliceal topography in the treatment of renal lower calyces stones with extracorporeal shock wave lithotripsy. 195
Clinical Factors Predicting Bilateral Lymph Node Invasion in High-Risk Prostate Cancer 195
NOCTURIA IN MALES WITH LUTS: PREVALENCE AND COMPARISON BETWEEN INTERNATIONAL PROSTATE SYMPTOM SCORE (IPSS) AND FREQUENCY-VOLUME CHARTS. AN OBSERVATIONAL, PROSPECTIVE DOUBLE-CENTRE STUDY 195
A COMPARISON OF VOIDED VOLUMES BETWEEN VOIDING DIARIES AND UROFLOWMETRY 195
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 193
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis. 193
Simultaneous Measurements of Follicle Stimulating Hormone and Total Testosterone and Associations in Clinically Localized Prostate Cancer 193
NOCTURIA IN MALES WITH LUTS: PREVALENCE AND COMPARISON BETWEEN INTERNATIONAL PROSTATE SYMPTOM SCORE AND FREQUENCY-VOLUME CHARTS. AN OBSERVATIONAL, PROSPECTIVE DOUBLE-CENTRE STUDY 193
Late complications after intravaginal slingplasty for female stress urinary incontinence 192
Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set 192
SACRAL NEUROMODULATION FOR THE TREATMENT OF REFRACTORY LOWER URINARY TRACT DYSFUNCTION: RESULTS FROM A MULTICENTER STUDY 191
Robotic-assisted radical prostatectomy is less stressful than the open approach: results of a contemporary prospective study evaluating pathophysiology of cortisol stress-related kinetics in prostate cancer surgery 190
COMPRENSIONE AMBULATORIALE DEL QUESTIONARIO IIEF-5 189
Robotic bladder diverticulectomy: step-by-step extravesical posterior approach - technique and outcomes 189
External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. 189
MP5-17 QUALITY OF LIFE IN SURVIVORS FROM RADICAL CYSTECTOMY. THE USE OF QUALITATIVE ANALYSIS 188
Basal total testosterone serum levels predict biopsy and pathological ISUP grade group in a large cohort of Caucasian prostate cancer patients who underwent radical prostatectomy 188
Mathematical models for prognostic prediction in patients with renal cell carcinoma. 187
Clinical Factors Predicting Tumour Upgrading in Patients Under Active Surveillance and Elected to Active Treatment after Disease Reclassification or Progression 187
Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study 187
Endogenous testosterone as a predictor of prostate growing disorders in the aging male 187
Lymphatic and vascular embolizations are independent predictive variables of inguinal lymph node involvement in patients with squamous cell carcinoma of the penis: Gruppo Uro-oncologico del Nord-est 185
Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection 185
IMPACT OF PREOPERATIVE PATIENTS' CHARACTERISTICS AND FLOW RATE ON FAILURE, EARLY COMPLICATIONS AND VOIDING DYSFUNCTION AFTER TRANSOBTURATORY TAPE PROCEDURE: A RETROSPECTIVE MULTI-CENTRE STUDY 185
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 185
High surgeon volume and positive surgical margins can predict the risk of biochemical recurrence after robot-assisted radical prostatectomy 184
COMPARISON OF THE LONG-TERM OUTCOMES OF MIDDLE URETHRAL SLING VERSUS MIDDLE URETHRAL SLING PLUS ANTERIOR VAGINAL REPAIR FOR CYSTOCELE - DOES ANTERIOR REPAIR INFLUENCE RESULTS ON CONTINENCE? 184
Continence and complications rates after male slings as primary surgery for post-prostatectomy incontinence: a systematic review. 182
Pain assessment after original transperineal prostate biopsy using a coaxial needle. 181
PURE STRESS URINARY INCONTINENCE: ANALYSIS OF THE PREVALENCE, ESTIMATION OF COSTS AND FINANCIAL IMPACT. 180
Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires 179
High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy 178
Long-term follow-up of anterior vaginal repair: A comparison among colporrhaphy, colporrhaphy with reinforcement by xenograft, and mesh 178
Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set 178
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 178
Positive Association between Basal Total Testosterone Circulating Levels and Tumor Grade Groups at the Time of Diagnosis of Prostate Cancer 178
43rd Annual Congress of the Italian Urodynamic Society, Rome, Italy, 13th-15th June 2019: Sacral neuromodulation in patients with lower urinary tract symptoms and affected by epilepsy: a multicentre study 177
Modified antegrade scrotal sclerotherapy in adolescent patients with varicocele 176
Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy 176
Low Preoperative Prolactin Levels Predict Non-Organ Confined Prostate Cancer in Clinically Localized Disease 174
Health-related Quality of Life After Radical Cystectomy: A Cross-sectional Study With Matched-pair Analysis on Ileal Conduit vs Ileal Orthotopic Neobladder Diversion 174
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 174
Totale 20.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.012
article - articoli 154.686
book - libri 0
conference - conferenze 11.012
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.314
Totale 334.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.238 0 0 0 0 77 62 46 140 81 57 132 643
2022/20234.671 345 395 455 811 392 1.156 48 345 517 29 119 59
2023/20242.349 111 183 171 285 333 355 78 160 26 153 372 122
2024/20256.015 322 443 215 1.064 355 165 250 245 954 382 467 1.153
2025/202618.754 1.255 771 1.201 2.999 4.783 1.339 1.774 970 1.500 1.230 303 629
2026/20273.797 214 508 824 2.109 142 0 0 0 0 0 0 0
Totale 47.584